PRESS RELEASE published on 11/26/2024 at 17:45, 1 year 3 months ago Valneva Submits Label Extension Application for its Chikungunya Vaccine, IXCHIQ®, to the U.S. FDA Valneva submits label extension application to U.S. FDA for its chikungunya vaccine, IXCHIQ®, to potentially include adolescents aged 12 to 17 years and two-year antibody persistence data FDA Valneva Chikungunya Vaccine IXCHIQ Label Extension Application
BRIEF published on 10/10/2024 at 07:05, 1 year 5 months ago Valneva presents its outlook at an investor day in New York Investors Growth Valneva Vaccines Lyme
PRESS RELEASE published on 10/10/2024 at 07:00, 1 year 5 months ago Valneva Hosts Investor Day in New York City Valneva SE is hosting an investor day in New York City to discuss key value drivers, including Lyme disease vaccine, commercial vaccines, and R&D pipeline. Hybrid event with webcast and Q&A sessions Investor Day Valneva SE Lyme Disease Vaccine R&D Pipeline Commercial Vaccines
BRIEF published on 10/04/2024 at 07:35, 1 year 5 months ago Valneva SE Announces Changes in Shares and Voting Rights Euronext Paris Voting Rights Shares Capital Increase Valneva SE
PRESS RELEASE published on 10/04/2024 at 07:30, 1 year 5 months ago Valneva SE - Declaration of shares and voting rights - September 30, 2024 Valneva declares changes in shares and voting rights, including a transfer into bearer form and a capital increase without preferential subscription rights Voting Rights Shares Capital Increase Transfer Valneva
BRIEF published on 10/03/2024 at 07:05, 1 year 5 months ago Valneva to Hold Investor Day in New York New York Investors Valneva Vaccines Chikungunya
PRESS RELEASE published on 10/03/2024 at 07:00, 1 year 5 months ago Valneva to Host Investor Day in New York on Thursday, October 10, 2024 at 10:00 AM ET Valneva SE to host Investor Day at Lotte New York Palace Hotel on Thursday, October 10, 2024, focusing on R&D pipeline and revenue-generating vaccines Investor Day Valneva SE Vaccine R&D Pipeline Lotte New York Palace Hotel
BRIEF published on 09/23/2024 at 15:51, 1 year 6 months ago Valneva Bolstered by Capital Raise Amid Strategic Focus on Vaccine Development BUY Rating Valneva SE Vaccine Development Equity Research Capital Raise
PRESS RELEASE published on 09/23/2024 at 15:46, 1 year 6 months ago Original-Research: Valneva SE (von First Berlin Equity Research GmbH): Buy First Berlin Equity Research updates Valneva SE (FR0004056851) with a BUY rating and a decreased price target to €7.70, reflecting the recent capital raise completed on 13 September 2024 BUY Rating Price Target Valneva SE Equity Research Capital Raise
BRIEF published on 09/23/2024 at 10:59, 1 year 6 months ago Bpifrance crosses the threshold of 10% of VALNEVA voting rights downwards Capital AMF Valneva Threshold Crossing Bpifrance
Published on 03/26/2026 at 08:05, 1 hour 21 minutes ago Vanta Announces U.S. Ticker Symbol Change to VNTXF
Published on 03/26/2026 at 04:55, 4 hours 31 minutes ago Vanta Announces Capital Markets Initiatives to Strengthen Financial Position and Support Growth Initiatives
Published on 03/26/2026 at 00:40, 8 hours 46 minutes ago Challenger RC Resource Upgrade Drilling Complete
Published on 03/26/2026 at 00:30, 8 hours 56 minutes ago Nano One Highlights Recent Objectives & Reports Fourth Quarter 2025 Results
Published on 03/25/2026 at 19:15, 14 hours 11 minutes ago Gemina Laboratories Ltd. Announces Delisting from the CSE
Published on 03/26/2026 at 09:05, 20 minutes ago Rockwell Automation Showcases Autonomous Industrial Operations at Hannover Messe 2026
Published on 03/26/2026 at 09:00, 25 minutes ago Original-Research: ZEAL Network SE (von NuWays AG): BUY
Published on 03/26/2026 at 09:00, 25 minutes ago Original-Research: INDUS Holding AG (von NuWays AG): BUY
Published on 03/26/2026 at 07:30, 1 hour 56 minutes ago BIOPHYTIS-LYNXKITE ALLIANCE INVITED TO NVIDIA CONFERENCE: UNLEASHING AI TO REVOLUTIONIZE LONGEVITY
Published on 03/25/2026 at 18:31, 14 hours 54 minutes ago Strong investment performance and active roll-out of our strategy
Published on 03/25/2026 at 17:45, 15 hours 41 minutes ago Combined General Meeting on May 05, 2026: publication of the notice of Meeting
